Viewing data from:

TRIMETHOBENZAMIDE HYDROCHLORIDE

ANDA

TRIMETHOBENZAMIDE HYDROCHLORIDE | A205950 | HERITAGE PHARMA LABS INC DBA AVET PHARMACEUTICALS LABS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$18.00

per ea

Lowest NADAC/Unit

$18.00

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135077330TRIMETHOBENZAMIDE 300 MG CAP	$18.00	EA	Generic	—	2025-09-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs2 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

EMCURE PHARMACEUTICALS LTDTRIMETHOBENZAMIDE HYDROCHLORIDE USP

DMF 269502013

KALINTIS HEALTHCARE PRIVATE LTDTRIMETHOBENZAMIDE HYDROCHLORIDE

DMF 439232026

FABBRICA ITALIANA SINTETICI SPAInactiveTRIMETHOBENZAMIDE HYDROCHLORIDE

DMF 77211988

DK PHARMA CHEM PVT LTDInactiveTRIMETHOBENZAMIDE HYDROCHLORIDE USP

DMF 274282014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 300MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Nov 21, 2023

No patent or exclusivity listings for this strength.